V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10018584 | 10070767 | 1.88 | 75.9 | 03 | 2021-10-05 | 2022-03-03 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101088419 |
| 10028309 | 10070769 | 1.62 | 80 | Palliative (P) | 2019-01-18 | 2020-12-05 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101306915 |
| 10030463 | 10070770 | 1.64 | 83 | 03 | null | 2021-07-20 | Avelumab | 02 | N | AVELUMAB | 100517013 |
| 10037048 | 10070771 | 1.86 | 49 | Adjuvant (A) | 2017-11-01 | 2018-09-19 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101344549 |
| 10037227 | 10070772 | 1.72 | 84 | 03 | 2021-09-01 | 2021-09-04 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101371464 |
| 10042327 | 10070773 | 1.68 | 62 | 03 | 2018-05-30 | 2019-08-20 | Avelumab | 02 | N | DARATUMUMAB | 101033870 |
| 10049798 | 10070776 | 1.71 | 71 | null | 2020-06-11 | 2021-02-03 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 100625952 |
| 10051750 | 10070777 | 1.72 | 78.25 | Palliative (P) | 2018-06-30 | 2020-06-03 | Venetoclax | 02 | null | VENETOCLAX | 100309116 |
| 10055637 | 10070779 | 1.64 | 45.8 | Palliative (P) | 2019-04-19 | 2021-03-07 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101433600 |
| 10058477 | 10070781 | 1.62 | 61 | Palliative (P) | 2016-01-19 | 2016-09-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101737185 |
| 10064100 | 10070782 | 1.47 | null | null | null | 2020-09-29 | Avelumab | 02 | null | AVELUMAB | 100807441 |
| 10073652 | 10070783 | 1.86 | 72.4 | null | 2020-02-22 | 2020-03-02 | CEMIPLIMAB | null | null | CEMIPLIMAB | 101210565 |
| 10075178 | 10070784 | 1.66 | 80.5 | Palliative (P) | 2021-01-09 | 2021-04-19 | Avelumab | 02 | N | DARATUMUMAB | 101049512 |
| 10085293 | 10070785 | 0 | 67.4 | Palliative (P) | 2021-06-25 | 2021-07-13 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101221821 |
| 10087201 | 10070786 | 0 | 83.9 | null | 2019-10-03 | 2019-10-19 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100557359 |
| 10091197 | 10070787 | 1.74 | 70 | null | 2021-07-25 | 2021-08-21 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101301313 |
| 10094662 | 10070788 | 0 | 88.4 | null | 2021-06-19 | 2021-08-09 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100723532 |
| 10100653 | 10070789 | 0 | 77.4 | null | 2021-07-14 | 2021-07-14 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101035928 |
| 10103476 | 10070791 | 1.63 | 53 | null | 2022-05-14 | 2022-05-20 | Avelumab | N | null | AVELUMAB | 100440302 |
| 10114484 | 10070792 | 1.76 | 79.5 | null | 2021-06-19 | 2021-07-07 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100430739 |
| 10121867 | 10070793 | 1.65 | 63.4 | null | 2020-04-23 | 2020-06-14 | Avelumab | 02 | null | DARATUMUMAB | 101375454 |
| 10126468 | 10070794 | 1.56 | 62.4 | Palliative (P) | 2021-08-21 | 2021-08-22 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100006212 |
| 10138617 | 10070795 | 1.77 | 93 | 03 | 2017-12-31 | 2018-01-05 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101005405 |
| 10140465 | 10070797 | 1.7 | null | null | 2019-03-23 | 2019-05-20 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100642987 |
| 10140587 | 10070798 | 1.75 | 0 | Palliative (P) | 2022-04-15 | 2022-04-17 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101591233 |
| 10143751 | 10070799 | 1.53 | 70 | Palliative (P) | 2021-10-24 | 2021-11-09 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100323751 |
| 10146407 | 10070801 | 1.58 | 62.8 | 03 | 2020-09-28 | 2020-11-14 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 100737526 |
| 10158411 | 10070803 | 1.74 | 76.5 | Palliative (P) | 2018-11-06 | 2019-10-21 | DARATUMUMAB | 02 | N | AVELUMAB | 101659045 |
| 10161709 | 10070804 | 1.61 | 101.3 | null | 2020-08-09 | 2020-11-14 | Avelumab | 02 | null | VENETOCLAX | 100645879 |
| 10164254 | 10070805 | 1.93 | 62.3 | null | 2021-12-04 | 2021-12-04 | Venetoclax | 02 | null | VENETOCLAX | 101460626 |
| 10168334 | 10070806 | 1.86 | 69 | Palliative (P) | null | 2022-01-08 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101071948 |
| 10169424 | 10070808 | 1.61 | 92 | Curative (C) | 2018-10-17 | 2018-10-29 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100660211 |
| 10170001 | 10070809 | 1.62 | 0 | null | 2020-11-27 | 2021-02-11 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101077469 |
| 10186199 | 10070813 | 1.76 | 107.3 | Disease modification (D) | 2020-05-06 | 2020-05-27 | Avelumab | N | N | CARBOPLATIN + GEMCITABINE | 101743237 |
| 10191357 | 10070814 | 1.77 | 67.2 | 03 | 2021-09-21 | 2021-12-19 | Venetoclax | 02 | N | VENETOCLAX | 100572795 |
| 10201773 | 10070815 | 1.62 | 0 | null | 2022-02-27 | 2022-03-19 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101630524 |
| 10203444 | 10070816 | 1.81 | null | 03 | 2021-05-22 | 2021-06-18 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 101769905 |
| 10206060 | 10070819 | 1.83 | 93.9 | 03 | 2020-04-08 | 2020-04-10 | Avelumab | 02 | N | VENETOCLAX | 100933397 |
| 10206452 | 10070820 | null | 96.05 | null | 2020-11-26 | 2020-11-27 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100500639 |
| 10206789 | 10070821 | 1.69 | 47.6 | Adjuvant (A) | 2017-10-28 | 2017-11-25 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101527823 |
| 10208849 | 10070823 | 1.62 | 105 | null | 2020-06-04 | 2020-06-04 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100114234 |
| 10209468 | 10070824 | 1.59 | 82.8 | Adjuvant (A) | 2018-12-08 | 2019-11-09 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 100484995 |
| 10209795 | 10070825 | 1.58 | 68.3 | Palliative (P) | 2021-02-07 | 2021-12-24 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100460136 |
| 10209860 | 10070826 | 1.57 | 72.75 | 03 | 2020-02-07 | 2020-02-07 | Avelumab | 02 | N | AVELUMAB | 101658124 |
| 10209910 | 10070827 | 1.8 | null | Palliative (P) | 2022-04-19 | 2022-05-17 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100011953 |
| 10209994 | 10070828 | 1.82 | 81.8 | null | 2018-12-06 | 2019-09-27 | Oxaliplatin + Modified de Gramont | 02 | null | FLUOROURACIL + OXALIPLATIN | 100980107 |
| 10210142 | 10070829 | 1.71 | 79.85 | Palliative (P) | 2020-02-29 | 2020-03-30 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100073099 |
| 10210868 | 10070830 | 1.71 | null | null | 2021-07-19 | 2021-07-19 | Avelumab | 02 | null | DARATUMUMAB | 100490163 |
| 10214003 | 10070832 | 1.73 | 88.4 | 03 | 2021-07-15 | 2021-07-15 | Avelumab | 02 | N | AVELUMAB | 101153356 |
| 10218005 | 10070834 | 1.5 | 81 | Palliative (P) | 2017-10-15 | 2017-10-16 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101762117 |